Ftse Mib
33.167,64
-0,78%
DAX
19.295,98
-0,59%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
92.787,32
0,89%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Homology Medicines Inc (FIXX) Homology Medicines Inc (FIXX) Notizie

FIXX

Homology Medicines (FIXX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FIXX
DataOraFonteTitoloSimboloCompagnia
18/03/202421:30GlobeNewswire Inc.Homology Medicines Declares Distribution to Common StockholdersNASDAQ:FIXXHomology Medicines Inc
11/03/202412:37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
11/03/202412:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
15/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FIXXHomology Medicines Inc
13/02/202416:11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FIXXHomology Medicines Inc
05/01/202423:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
03/01/202422:08GlobeNewswire Inc.Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyNASDAQ:FIXXHomology Medicines Inc
11/12/202322:15Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FIXXHomology Medicines Inc
17/11/202322:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
16/11/202313:05GlobeNewswire Inc.Q32 Bio and Homology Medicines Announce Merger AgreementNASDAQ:FIXXHomology Medicines Inc
14/11/202322:33GlobeNewswire Inc.Homology Medicines Reports Third Quarter 2023 Financial ResultsNASDAQ:FIXXHomology Medicines Inc
14/08/202322:05GlobeNewswire Inc.Homology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
14/08/202322:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FIXXHomology Medicines Inc
27/07/202322:05GlobeNewswire Inc.Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKUNASDAQ:FIXXHomology Medicines Inc
27/07/202322:01GlobeNewswire Inc.Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKUNASDAQ:FIXXHomology Medicines Inc
16/06/202301:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FIXXHomology Medicines Inc
14/06/202322:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FIXXHomology Medicines Inc
16/05/202314:00GlobeNewswire Inc.Homology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual MeetingNASDAQ:FIXXHomology Medicines Inc
11/05/202322:05GlobeNewswire Inc.Homology Medicines Reports First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
11/05/202322:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FIXXHomology Medicines Inc
03/05/202313:30GlobeNewswire Inc.Homology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual MeetingNASDAQ:FIXXHomology Medicines Inc
28/04/202323:58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FIXXHomology Medicines Inc
28/04/202322:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FIXXHomology Medicines Inc
28/04/202322:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FIXXHomology Medicines Inc
20/03/202311:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FIXXHomology Medicines Inc
16/03/202322:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FIXXHomology Medicines Inc
15/03/202321:01GlobeNewswire Inc.Homology Medicines Announces Presentations on Design of Ongoing Gene Editing and Gene Therapy Trials for PKU and Hunter Syndrome at ACMG Annual Clinical Genetics MeetingNASDAQ:FIXXHomology Medicines Inc
09/03/202322:34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FIXXHomology Medicines Inc
09/03/202322:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FIXXHomology Medicines Inc
09/03/202322:05GlobeNewswire Inc.Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FIXX

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
MONC
Moncler
BIT
SPM
Saipem
BIT
G
Generali
BIT
CPR
Davide Campari
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
TEN
Tenaris
BIT
PIRC
Pirelli & C
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network